Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itopride HCI in IBS-C
NCT01027260Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of itopride in irritable bowel syndrome (IBS), sponsored by Abbott Laboratories. Started Jun 2008; status: completed.
02
Drugs
itopride
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01027260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01027260.